- REPORT SUMMARY
- TABLE OF CONTENTS
-
A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
This report elaborates on the current development of the Non-prescription Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Johnson & Johnson
Shire
Takeda
Roche
Eli Lilly
Teva
Pfizer
Allergan
AbbVie
Bristol-Myers Squibb
Sanofi
GlaxoSmithKline (GSK)
Boehringer Ingelheim
Novartis
AstraZeneca
Novo Nordisk
Amgen
Bayer
Gilead Sciences
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Brand Drugs
Generic Drug
Application:
Hospital
Clinic
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Non-prescription Drugs Industry Overview
-
1.1.1 Non-prescription Drugs Market Scope and Market Segments
-
1.1.2 Non-prescription Drugs Industry Characteristics
-
1.1.3 Global and China Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Non-prescription Drugs Production Value and Growth Rate (2017-2028)
-
1.2 Global Non-prescription Drugs Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Brand Drugs
-
1.2.2 Generic Drug
-
1.3 Global Non-prescription Drugs Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Clinic
-
1.3.3 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Non-prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Non-prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Non-prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Non-prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Non-prescription Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Non-prescription Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Non-prescription Drugs Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Non-prescription Drugs Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Non-prescription Drugs Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Non-prescription Drugs Industry Porter's Five Forces Model Analysis
-
2.2.3 Non-prescription Drugs Industry PEST Analysis
-
2.3 Non-prescription Drugs Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Non-prescription Drugs Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Non-prescription Drugs Industry
Chapter 3 Global and China Non-prescription Drugs Market, by Manufacturer
-
3.1 Global and China Non-prescription Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Non-prescription Drugs Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Non-prescription Drugs Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Non-prescription Drugs Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Non-prescription Drugs Market Top 3 Players
Chapter 4 Global and China Non-prescription Drugs Market, by Type (2017-2028)
-
4.1 Non-prescription Drugs Market Trend, by Type
-
4.2 Global Non-prescription Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Non-prescription Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Non-prescription Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Non-prescription Drugs Price Trend, by Type (2017-2028)
-
4.3 China Non-prescription Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Non-prescription Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Non-prescription Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Non-prescription Drugs Price Trend, by Type (2017-2028)
Chapter 5 Global and China Non-prescription Drugs Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Non-prescription Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Non-prescription Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Non-prescription Drugs Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Non-prescription Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Non-prescription Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Non-prescription Drugs Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Non-prescription Drugs Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Non-prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Non-prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Non-prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Non-prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Non-prescription Drugs Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Non-prescription Drugs Market Analysis
-
7.1 North America Non-prescription Drugs Market, by Type
-
7.2 North America Non-prescription Drugs Market, by Application
-
7.3 North America Non-prescription Drugs Market Analysis and Forecast, by Country
-
7.3.1 United States Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Non-prescription Drugs Market Analysis
-
8.1 Europe Non-prescription Drugs Market, by Type
-
8.2 Europe Non-prescription Drugs Market, by Application
-
8.3 Europe Non-prescription Drugs Market Analysis and Forecast, by Country
-
8.3.1 Germany Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Non-prescription Drugs Market Analysis
-
9.1 APAC Non-prescription Drugs Market, by Type
-
9.2 APAC Non-prescription Drugs Market, by Application
-
9.3 APAC Non-prescription Drugs Market Analysis and Forecast, by Country
-
9.3.1 China Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Non-prescription Drugs Market Analysis
-
10.1 Latin America, Middle East and Africa Non-prescription Drugs Market, by Type
-
10.2 Latin America, Middle East and Africa Non-prescription Drugs Market, by Application
-
10.3 Latin America, Middle East and Africa Non-prescription Drugs Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Non-prescription Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Non-prescription Drugs Company Profiles
-
11.1 Johnson & Johnson
-
11.1.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Johnson & Johnson Non-prescription Drugs Product Profiles, Application and Specification
-
11.1.3 Johnson & Johnson Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Shire
-
11.2.1 Shire Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Shire Non-prescription Drugs Product Profiles, Application and Specification
-
11.2.3 Shire Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Takeda
-
11.3.1 Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Takeda Non-prescription Drugs Product Profiles, Application and Specification
-
11.3.3 Takeda Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Roche
-
11.4.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Roche Non-prescription Drugs Product Profiles, Application and Specification
-
11.4.3 Roche Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Eli Lilly
-
11.5.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Eli Lilly Non-prescription Drugs Product Profiles, Application and Specification
-
11.5.3 Eli Lilly Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Teva
-
11.6.1 Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Teva Non-prescription Drugs Product Profiles, Application and Specification
-
11.6.3 Teva Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Pfizer
-
11.7.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Pfizer Non-prescription Drugs Product Profiles, Application and Specification
-
11.7.3 Pfizer Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Allergan
-
11.8.1 Allergan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Allergan Non-prescription Drugs Product Profiles, Application and Specification
-
11.8.3 Allergan Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 AbbVie
-
11.9.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 AbbVie Non-prescription Drugs Product Profiles, Application and Specification
-
11.9.3 AbbVie Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Bristol-Myers Squibb
-
11.10.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Bristol-Myers Squibb Non-prescription Drugs Product Profiles, Application and Specification
-
11.10.3 Bristol-Myers Squibb Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Sanofi
-
11.11.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Sanofi Non-prescription Drugs Product Profiles, Application and Specification
-
11.11.3 Sanofi Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 GlaxoSmithKline (GSK)
-
11.12.1 GlaxoSmithKline (GSK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 GlaxoSmithKline (GSK) Non-prescription Drugs Product Profiles, Application and Specification
-
11.12.3 GlaxoSmithKline (GSK) Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Boehringer Ingelheim
-
11.13.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Boehringer Ingelheim Non-prescription Drugs Product Profiles, Application and Specification
-
11.13.3 Boehringer Ingelheim Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Novartis
-
11.14.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Novartis Non-prescription Drugs Product Profiles, Application and Specification
-
11.14.3 Novartis Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 AstraZeneca
-
11.15.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 AstraZeneca Non-prescription Drugs Product Profiles, Application and Specification
-
11.15.3 AstraZeneca Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Novo Nordisk
-
11.16.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Novo Nordisk Non-prescription Drugs Product Profiles, Application and Specification
-
11.16.3 Novo Nordisk Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.17 Amgen
-
11.17.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.17.2 Amgen Non-prescription Drugs Product Profiles, Application and Specification
-
11.17.3 Amgen Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.18 Bayer
-
11.18.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.18.2 Bayer Non-prescription Drugs Product Profiles, Application and Specification
-
11.18.3 Bayer Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.19 Gilead Sciences
-
11.19.1 Gilead Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.19.2 Gilead Sciences Non-prescription Drugs Product Profiles, Application and Specification
-
11.19.3 Gilead Sciences Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Non-prescription Drugs Industry Investment Prospect and Risk Assessment
-
12.1 Non-prescription Drugs Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Non-prescription Drugs Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Global Non-prescription Drugs Production Value and Growth Rate (2017-2028)
-
Figure China Non-prescription Drugs Production Value and Growth Rate (2017-2028)
-
Figure Global Non-prescription Drugs Market Size and Growth Rate of Brand Drugs (2017-2028)
-
Figure Global Non-prescription Drugs Market Size and Growth Rate of Generic Drug (2017-2028)
-
Figure Global Non-prescription Drugs Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Non-prescription Drugs Market Size and Growth Rate of Clinic (2017-2028)
-
Figure Global Non-prescription Drugs Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Non-prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Non-prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Non-prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Non-prescription Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Non-prescription Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Non-prescription Drugs Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Non-prescription Drugs Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Non-prescription Drugs Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Non-prescription Drugs Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Non-prescription Drugs Market Share, by Manufacturer in 2021
-
Figure Global and China Non-prescription Drugs Market Share, by Manufacturer in 2022
-
Table Global Non-prescription Drugs Sales Volume, by Type (2017-2028)
-
Table Global Non-prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Global Non-prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Table Global Non-prescription Drugs Sales Value, by Type (2017-2028)
-
Table Global Non-prescription Drugs Sales Value Share, by Type (2017-2028)
-
Figure Global Non-prescription Drugs Price Trend, by Type (2017-2028)
-
Table China Non-prescription Drugs Sales Volume, by Type (2017-2028)
-
Table China Non-prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Figure China Non-prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Table China Non-prescription Drugs Sales Value, by Type (2017-2028)
-
Table China Non-prescription Drugs Sales Value Share, by Type (2017-2028)
-
Figure China Non-prescription Drugs Price Trend, by Type (2017-2028)
-
Table Global Non-prescription Drugs Sales Volume, by Application (2017-2028)
-
Table Global Non-prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Global Non-prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Table Global Non-prescription Drugs Sales Value, by Application (2017-2028)
-
Table Global Non-prescription Drugs Sales Value Share, by Application (2017-2028)
-
Figure Global Non-prescription Drugs Sales Value Share, by Application (2017-2028)
-
Table China Non-prescription Drugs Sales Volume, by Application (2017-2028)
-
Table China Non-prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Non-prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Table China Non-prescription Drugs Sales Value, by Application (2017-2028)
-
Table China Non-prescription Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Non-prescription Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Non-prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure North America Non-prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Non-prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Non-prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Non-prescription Drugs Production, Import, Consumption and Export (2017-2022)
-
Table North America Non-prescription Drugs Sales Volume, by Type (2017-2028)
-
Table North America Non-prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Figure North America Non-prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Table North America Non-prescription Drugs Sales Volume, by Application (2017-2028)
-
Table North America Non-prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure North America Non-prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure United States Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure United States Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Canada Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Table Europe Non-prescription Drugs Sales Volume, by Type (2017-2028)
-
Table Europe Non-prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Europe Non-prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Table Europe Non-prescription Drugs Sales Volume, by Application (2017-2028)
-
Table Europe Non-prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Europe Non-prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Germany Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure UK Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure UK Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure France Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure France Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Italy Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Spain Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Poland Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Russia Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Table APAC Non-prescription Drugs Sales Volume, by Type (2017-2028)
-
Table APAC Non-prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Figure APAC Non-prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Table APAC Non-prescription Drugs Sales Volume, by Application (2017-2028)
-
Table APAC Non-prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure APAC Non-prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Japan Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure India Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure India Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Non-prescription Drugs Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Non-prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Non-prescription Drugs Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Non-prescription Drugs Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Non-prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Non-prescription Drugs Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Non-prescription Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Non-prescription Drugs Sales Value and Growth Rate (2017-2028)
-
Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Johnson & Johnson Product Profiles, Application and Specification
-
Table Johnson & Johnson Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Shire Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Shire Product Profiles, Application and Specification
-
Table Shire Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Takeda Product Profiles, Application and Specification
-
Table Takeda Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Roche Product Profiles, Application and Specification
-
Table Roche Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly Product Profiles, Application and Specification
-
Table Eli Lilly Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teva Product Profiles, Application and Specification
-
Table Teva Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Allergan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Allergan Product Profiles, Application and Specification
-
Table Allergan Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AbbVie Product Profiles, Application and Specification
-
Table AbbVie Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GlaxoSmithKline (GSK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GlaxoSmithKline (GSK) Product Profiles, Application and Specification
-
Table GlaxoSmithKline (GSK) Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Boehringer Ingelheim Product Profiles, Application and Specification
-
Table Boehringer Ingelheim Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca Product Profiles, Application and Specification
-
Table AstraZeneca Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novo Nordisk Product Profiles, Application and Specification
-
Table Novo Nordisk Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bayer Product Profiles, Application and Specification
-
Table Bayer Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Gilead Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Gilead Sciences Product Profiles, Application and Specification
-
Table Gilead Sciences Non-prescription Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-

Chinese